hrcak mascot   Srce   HID

Pregledni rad

New Classification of Hematopoietic Malignancy

Boris Labar

Puni tekst: hrvatski, pdf (64 KB) str. 163-166 preuzimanja: 4.347* citiraj
APA 6th Edition
Labar, B. (2001). Podjela zloćudnih tumora krvotvornog sustava. Medicus, 10 (2_Maligni tumori), 163-166. Preuzeto s https://hrcak.srce.hr/19345
MLA 8th Edition
Labar, Boris. "Podjela zloćudnih tumora krvotvornog sustava." Medicus, vol. 10, br. 2_Maligni tumori, 2001, str. 163-166. https://hrcak.srce.hr/19345. Citirano 25.02.2021.
Chicago 17th Edition
Labar, Boris. "Podjela zloćudnih tumora krvotvornog sustava." Medicus 10, br. 2_Maligni tumori (2001): 163-166. https://hrcak.srce.hr/19345
Harvard
Labar, B. (2001). 'Podjela zloćudnih tumora krvotvornog sustava', Medicus, 10(2_Maligni tumori), str. 163-166. Preuzeto s: https://hrcak.srce.hr/19345 (Datum pristupa: 25.02.2021.)
Vancouver
Labar B. Podjela zloćudnih tumora krvotvornog sustava. Medicus [Internet]. 2001 [pristupljeno 25.02.2021.];10(2_Maligni tumori):163-166. Dostupno na: https://hrcak.srce.hr/19345
IEEE
B. Labar, "Podjela zloćudnih tumora krvotvornog sustava", Medicus, vol.10, br. 2_Maligni tumori, str. 163-166, 2001. [Online]. Dostupno na: https://hrcak.srce.hr/19345. [Citirano: 25.02.2021.]

Sažetak
A new classification of hematopoietic malignancy
according to World Health Organization is reported. In
this classification myeloid and lymphoid malignancies as well
as malignant tumours of mastocyte and histocyte and dendritic
cells are included. A new group of lymphoproliferative
diseases following organ and tissue transplantation is recognized.
Clinical and prognostic factors are the most relevant
factors which determine new WHO classification.

Ključne riječi
classification; malignant tumours; hematopoietic tissue

Hrčak ID: 19345

URI
https://hrcak.srce.hr/19345

[hrvatski]

Posjeta: 4.861 *